Non-small cell lung cancer recurrent

Clinical trials for Non-small cell lung cancer recurrent explained in plain language.

Never miss a new study

Get alerted when new Non-small cell lung cancer recurrent trials appear

Sign up with your email to follow new studies for Non-small cell lung cancer recurrent, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Terminated 1

Could a lung cancer drug designed for one mutation work for another?

Disease control Stopped early

This phase II trial tests whether alectinib, a drug typically used for ALK-positive lung cancer, can shrink tumors or control disease in people with advanced non-small cell lung cancer that has a RET gene rearrangement and has progressed after prior treatment. Participants take a…

Matched conditions: NON-SMALL CELL LUNG CANCER RECURRENT

Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC

Non-small cell lung cancer recurrent

Get alerted when new Non-small cell lung cancer recurrent trials appear

Could a lung cancer drug designed for one mutation work for another?